PHARMACEUTICAL PRODUCT MANUFACTURING - Risk Management Applications in Pharmaceutical and Biopharmaceutical Manufacturing - page 316

7. Coburn J., Levinson S.H., Weddle G., July 2008, A Precedent for Risk-Based
Regulation. Available at http://www.johnsoncontrols.com/publish/etc./medialib/jci/be
/commercial/capabilities/my_building__vertical/life_sciences/articles_and_white.Par.
27473.File.tmp/A%20Precedent%20for%20Risk-Based%20Regulation.pdf. Accessed
2100 Jul 18.
8. Therapeutic Goods Agency (TGA), May 2011, TGA's Risk Management Approach
to Regulation of Therapeutic Goods, Available at http://www.tga.gov.au/pdf/basics-
regulation-risk-management.pdf. Accessed 2011 Jul 18.
9. Ahmed R et al. PDA Survey of Quality Risk Management Practices in the Pharma-
ceutical, Devices, & Biotechnology Industries. PDA J Pharm Sci Technol January
2008;62(1):1-21.
10. Cox B., The Gold Sheet © , December 2009, Roche Builds Quality Risk Management
Program Response to Viracept Crisis.
11. The Chartered Quality Institute, 2010, A Guide to Supply Chain Risk Management
for the Pharmaceutical and Medical Device Industries and their Suppliers, Volume
1.0.
12. International Conference on Harmonisation (ICH), November 2005, Quality Risk
Management Q9. Available at http://www.ich.org/fileadmin/Public_Web_Site/ICH
_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf. Accessed 2011 Jul 18.
13. PIC/S, Quality Risk Management, Implementation of ICH Q9 in the Pharmaceu-
tical Field, An Example of Methodology from PIC/S, 2010 January. Available
at http://www.picscheme.org/bo/commun/upload/document/psinf012010exampleofqr
mimplementation.pdf. Accessed 2011 Jul 18.
14. International Conference on Harmonisation (ICH), November 2009, Q8(R2) Phar-
maceutical Development. Available at http://www.ich.org/fileadmin/Public_Web_Site
/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf. Accessed

2011 Jul 18.
15. International Conference on Harmonisation, June 2008, Pharmaceutical Qual-
ity System Q10. Available at http://www.ich.org/fileadmin/Public_Web_Site/ICH
_Products/Guidelines/Quality/Q10/Step4/Q10_Guideline.pdf. Accessed 2011 Jul 18.
16. United States Food and Drug Administration (FDA), Center for Drug Evaluation
and Research (CDER), Applying ICH Q8(R2), Q9, and Q10 Principles to CMC
Review (MAPP 5016.1), February 2011. Available at http://www.fda.gov/downloads
/AboutFDA/CentersOffices/CDER/ManualofPoliciesProcedures/UCM242665.pdf.
Accessed 2011 Jul 18.
17. Introduction to Quality Control by Kaoru Ishikawa, Jan 1, 1990).
18. Ahmed R., et al., March 2008, PDA Technical Report No. 44 (TR 44), Quality
Risk Management for Aseptic Processes, PDA Journal of Pharmaceutical Science
and Technology, Supplement Volume 62, No. S-1.
19. 21 CFR 211.
20. Miele, W., March 2001, PDA Annual Meeting, A Science and Risk Based Approach
to Microbiological Control of Manufacturing Environments Applicable to Multiple
Dosage Forms Produced in a Non-Sterile Setting.
21. United States Department of Agriculture (USDA), July 1996, Federal Registry,9
CFR Part 304, et al., Pathogen reduction, Hazard Analysis and Critical Control
Point (HACCP) Systems Final Rule. Available at http://www.fsis.usda.gov/Frame